Eli Lilly (LLY)

Ratings

3 / 5

Trading

3

4 / 5

Investing

4

3 / 5

ESG

3

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm’s products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies.

Related posts:

  1. Where next for GSK shares as its strategic pivot develops?
  2. Yen Bears Burden of BOJ’s Ultra-Loose Monetary Policy
  3. 5 best FTSE 100 stocks to watch in May 2022
  4. Apple Rises 11 Days in a Row, Best Record Since 2003
  5. Market Update – March 11/2022

Leave a Comment